Q2 2023 Holdings
Filed 2023-08-14 | 41 holdings | $718.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $238.5M | 2,618,300 | 33.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $52.2M | 2,468,000 | 7.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $50.1M | 4,570,918 | 7.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $40.0M | 1,968,000 | 5.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $39.4M | 3,904,000 | 5.5% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $27.1M | 750,000 | 3.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $25.8M | 759,898 | 3.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $22.0M | 923,000 | 3.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $21.0M | 1,219,200 | 2.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $20.2M | 1,066,784 | 2.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $18.4M | 415,000 | 2.6% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $15.9M | 650,100 | 2.2% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $15.5M | 2,368,587 | 2.2% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $11.7M | 474,929 | 1.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $10.7M | 621,712 | 1.5% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $7.9M | 596,000 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.8M | 692,945 | 1.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.7M | 367,000 | 1.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.7M | 750,000 | 1.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.6M | 495,000 | 1.1% |
| Geron Corp(GERN) | COM | 374163103 | $7.3M | 2,278,000 | 1.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $6.4M | 2,425,000 | 0.9% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $6.1M | 720,900 | 0.9% |
| Jasper Therapeutics Inc | COM | 471871103 | $6.1M | 4,468,114 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.1M | 375,000 | 0.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $5.8M | 1,660,000 | 0.8% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $5.2M | 3,000,000 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.7M | 3,958,069 | 0.7% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $4.4M | 1,923,076 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.1M | 75,000 | 0.4% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.9M | 470,000 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.5M | 411,928 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.1M | 277,000 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.0M | 185,669 | 0.3% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $2.0M | 50,000 | 0.3% |
| Hepion Pharmaceuticals Inc | COM NEW | 426897302 | $1.6M | 155,000 | 0.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.1M | 70,000 | 0.2% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.1M | 6,600,000 | 0.2% |
| Magenta Therapeutics Inc | COM | 55910K108 | $416.9K | 550,000 | 0.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $276.8K | 49,702 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $136.3K | 19,900 | 0.0% |